For research use only. Not for therapeutic Use.
RNase L-IN-1(CAT: I040987) is a potent and selective inhibitor of RNase L, an endoribonuclease involved in antiviral immune responses and RNA degradation pathways. By targeting RNase L, this inhibitor serves as a valuable tool for studying innate immunity, interferon signaling, and RNA metabolism. RNase L-IN-1 is particularly useful in infection disease research, including investigations into viral replication mechanisms and immune evasion strategies. It is suitable for biochemical, cellular, and preclinical studies exploring therapeutic interventions in viral infections, inflammation, and autoimmune disorders. For research use only; not for human or clinical applications.
| Synonyms | 5-[(E)-[4-(2-aminoethylcarbamoyl)-5-(3-fluorophenyl)imino-3-hydroxythiophen-2-ylidene]methyl]-N-[2-(diethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| Molecular Formula | C27H35FN6O3S |
| Purity | ≥95% |
| IUPAC Name | 5-[(E)-[4-(2-aminoethylcarbamoyl)-5-(3-fluorophenyl)imino-3-hydroxythiophen-2-ylidene]methyl]-N-[2-(diethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| InChI | InChI=1S/C27H35FN6O3S/c1-5-34(6-2)13-12-31-25(36)22-16(3)20(32-17(22)4)15-21-24(35)23(26(37)30-11-10-29)27(38-21)33-19-9-7-8-18(28)14-19/h7-9,14-15,32,35H,5-6,10-13,29H2,1-4H3,(H,30,37)(H,31,36)/b21-15+,33-27? |
| InChIKey | HXSWRABTASZTFO-ZOVZBSLZSA-N |
| SMILES | CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C(=C(C(=NC3=CC(=CC=C3)F)S2)C(=O)NCCN)O)C |
